Mind Cure Introduces iSTRYM-an Automated Therapy Platform

Mind Cure Introduces iSTRYM-an Automated Therapy Platform

By Healthcare Tech Outlook | Wednesday, January 13, 2021

Mind Cure's iSTRYM offers a digital approach to the lack of vital, uncategorized data points by integrating patient reviews and professional experience in one location.

FREMONT, CA: Mind Cure Health (MCUR), a mental health and wellness company, recently confirmed the introduction of iSTRYM, the company's automated therapy platform intended to include close-to-real-time details on medical treatment, treatments and guidelines, and other tools for therapists, practitioners, and patients with mental health issues.

Gaps between clients, researchers, and clinicians establish differences in the accumulation of crucial observations that occur beyond psychedelic-assisted therapy sessions and eventually discourage major scientific breakthroughs.

Mind Cure's iSTRYM offers a digital approach to the lack of vital, uncategorized data points by integrating patient reviews and professional experience in one location. Besides, the bulk of psychedelic therapy research occurs in cloistered scientific societies, restricting the potential intersection of effective clinical practice and new protocols. iSTRIM puts together a vast database of existing guidelines for all psychedelic practitioners, improving clinical effectiveness for the broader psychedelic research population.

ISTRYM is a centralized management framework for psychedelic clinical testing, treatment distribution, and integration based on a microservice architecture paradigm and is designed with sensitive concepts. iSTRIM includes strategic data loops that constantly aggregate new ideas and an application that equips patients as committed partners in their own emotional health path.

The goal of iSTRYM is to disrupt the mental health sector by offering open and creative technical tools that maximize the use of patient data to support diagnosis and care. The iSTRYM app element will document uncategorized patient data such as temperature, venue, mood, heart rate, and other measurements during therapy sessions and therapeutic integration. This protocol optimization, coupled with the iSTRYM AI, would establish a convergence of commonality between patients. ISTRYM can use AI to collect information through datasets to direct doctors to improve evaluations, therapies, and increasingly tailored care on a scale.

Weekly Brief